Biotech firm HX Diagnostics, based in Emeryville, Calif., has raised $3.12 million in a first round of funding from Kleiner Perkins Caufield & Byers, Nanogen and Xiamen YST Biotech, reports peHUB. The company says its mission is to develop rapid diagnostics for seasonal and emerging infectious diseases, partcularly different strains of influenza.